Deere & Company’s Anika Therapeutics ANIK Stock Holding History

Deere & Company’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-24,440	Closed	-$1.17M	–	64
2016 Q3	$1.17M	Hold	24,440	–	–	0.06%	352
2016 Q2	$1.31M	Buy	24,440 +16,375	+203%	+$772K	0.07%	267
2016 Q1	$361K	Sell	8,065 -33,279	-80%	-$1.35M	0.02%	737
2015 Q4	$1.58M	Buy	+41,344	New	+$1.58M	0.09%	266
2015 Q1	–	Sell	-11,807	Closed	-$481K	–	965
2014 Q4	$481K	Buy	+11,807	New	+$462K	0.03%	635
2013 Q4	–	Sell	-62,583	Closed	-$1.5M	–	985
2013 Q3	$1.5M	Buy	+62,583	New	+$1.4M	0.09%	237

Other funds holding ANIK

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deere & Company's ANIK Position: Q4 2016 in Review

Deere & Company sold out of Anika Therapeutics (ANIK) in Q4 2016, closing a stake of 24,440 shares — an estimated $1.17M sold.

Deere & Company first reported a position in ANIK in Q3 2013 and held it in 6 quarters. The position peaked at $1.58M in Q4 2015. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

Deere & Company reported no remaining Anika Therapeutics position as of Q4 2016 after selling out during the quarter.
Deere & Company sold 24,440 Anika Therapeutics shares in Q4 2016, an estimated $1.17M.
Deere & Company first reported a position in Anika Therapeutics in Q3 2013 and held it in 6 quarters.
Deere & Company's Anika Therapeutics position peaked at $1.58M in Q4 2015.
158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.